Affiliation:
1. SPRINZ, School of Sport and Recreation, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, NEW ZEALAND
2. Research and Development, The Nutraceutical Alliance, Burlington, Ontario, CANADA
Abstract
ABSTRACT
Purpose
This study aimed to determine whether (i) a plasma acidosis contributes to a reduction of mechanical performance and (ii) bicarbonate supplementation blunts plasma acidosis and arterial oxygen desaturation to resist fatigue during the end spurt of a supramaximal trial in elite sprint and endurance cyclists.
Methods
Elite/world-class cyclists (n = 6 sprint, n = 6 endurance) completed two randomized, double-blind, crossover trials at 105%V̇O2peak simulating 3 min of a 4-km individual pursuit, 90 min after ingestion of 0.3 g·kg−1 BM sodium bicarbonate (BIC) or placebo (PLA). Peak power output (PPO), optimal cadence and optimal peak torque, and fatigue were assessed using a 6-s “all-out sprint” before (PPO1) and after (PPO2) each trial. Plasma pH, bicarbonate, lactate−, K+, Na+, Ca2+, and arterial hemoglobin saturation (SpO2(%)), were measured.
Results
Sprint cyclists exhibited a higher PPO, optimal pedal torque, and anaerobic power reserve (APR) than endurance cyclists. The trial reduced PPO (PLA) more for sprint (to 47% initial) than endurance cyclists (to 61% initial). Optimal cadence fell from ~151 to 92 rpm and cyclists with higher APR exhibited a reduced optimal peak torque. Plasma pH fell from 7.35 to 7.13 and plasma [lactate−] increased from 1.2 to 19.6 mM (PLA), yet neither correlated with PPO loss. Sprint cyclists displayed a lesser plasma acidosis but greater fatigue than endurance cyclists. BIC increased plasma [HCO3
−] (+6.8 mM) and plasma pH after PPO1 (+0.09) and PPO2 (+0.07) yet failed to influence mechanical performance. SpO2 fell from 99% to 96% but was unrelated to the plasma acidosis and unaltered with BIC.
Conclusions
Plasma acidosis was not associated with the decline of PPO in a supramaximal trial with elite cyclists. BIC attenuated acid–base disturbances yet did not improve arterial oxygen desaturation or mechanical performance at the end-spurt stage.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physical Therapy, Sports Therapy and Rehabilitation,Orthopedics and Sports Medicine